Evaluation of progressive visual dysfunction and retinal degeneration in patients with parkinson’s disease

Satue, M. ; Rodrigo, M.J. ; Obis, J. ; Vilades, E. ; Gracia, H. ; Otin, S. (Universidad de Zaragoza) ; Fuertes, M.I. (Universidad de Zaragoza) ; Alarcia, R. ; Crespo, J.A. ; Polo, V. (Universidad de Zaragoza) ; Larrosa, J.M. (Universidad de Zaragoza) ; Pablo, L.E. (Universidad de Zaragoza) ; Garcia-Martin, E. (Universidad de Zaragoza)
Evaluation of progressive visual dysfunction and retinal degeneration in patients with parkinson’s disease
Resumen: PURPOSE. To quantify changes in visual function parameters and in the retinal nerve fiber layer and macular thickness over a 5-year period in patients with Parkinson’s disease (PD). METHODS. Thirty patients with PD and 30 healthy subjects underwent a complete ophthalmic evaluation, including assessment of visual acuity, contrast sensitivity vision, color vision, and retinal evaluation with spectral-domain optical coherence tomography (SD-OCT). All subjects were reevaluated after 5 years to quantify changes in visual function parameters, the retinal nerve fiber layer, and macular thickness. Association between progressive ophthalmologic changes and disease progression was analyzed. RESULTS. Changes were detected in visual function parameters and retinal nerve fiber layer thickness in patients compared with controls. Greater changes were found during the follow-up in the PD group than healthy subjects in visual acuity, contrast sensitivity, Lanthony color test (P < 0.016), in superotemporal and temporal retinal nerve fiber layer sectors (P < 0.001), and in macular thickness (all sectors except inner superior and inner inferior sectors, P < 0.001). Progressive changes in the retinal nerve fiber layer were associated with disease progression (r = 0.389, P = 0.028). CONCLUSIONS. Progressive visual dysfunction, macular thinning, and axonal loss can be detected in PD. Analysis of the macular thickness and the retinal nerve fiber layer by SD-OCT can be useful for evaluating Parkinson’s disease progression.
Idioma: Inglés
DOI: 10.1167/iovs.16-20460
Año: 2017
Publicado en: Investigative ophthalmology & visual science 58, 2 (2017), 1151-1157
ISSN: 0146-0404

Factor impacto JCR: 3.388 (2017)
Categ. JCR: OPHTHALMOLOGY rank: 9 / 59 = 0.153 (2017) - Q1 - T1
Factor impacto SCIMAGO: 2.058 - Cellular and Molecular Neuroscience (Q1) - Sensory Systems (Q1) - Ophthalmology (Q1)

Financiación: info:eu-repo/grantAgreement/ES/ISCIII/CM14-00026
Financiación: info:eu-repo/grantAgreement/ES/ISCIII/PI14-01499
Tipo y forma: Article (Published version)
Área (Departamento): Área Oftalmología (Dpto. Cirugía,Ginecol.Obstetr.)
Área (Departamento): Área Óptica (Dpto. Física Aplicada)


Creative Commons You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use. You may not use the material for commercial purposes. If you remix, transform, or build upon the material, you may not distribute the modified material.


Exportado de SIDERAL (2022-08-31-09:13:30)


Visitas y descargas

Este artículo se encuentra en las siguientes colecciones:
Articles > Artículos por área > Oftalmología
Articles > Artículos por área > Optica



 Record created 2022-08-31, last modified 2022-08-31


Versión publicada:
 PDF
Rate this document:

Rate this document:
1
2
3
 
(Not yet reviewed)